Latest News and Press Releases
Want to stay updated on the latest news?
-
CLEVELAND, Dec. 31, 2025 (GLOBE NEWSWIRE) -- Abeona Therapeutics Inc. (Nasdaq: ABEO) today announced it has granted equity awards to new executive and non-executive employees who joined the Company....
-
MedSell commercializes Lumee™ Oxygen tissue monitoring in France, building upon distributor partnerships in Spain, Germany, the Benelux countries, Austria, the United Kingdom, and Scandinavia, to now...
-
FDA grants AXS-05 Priority Review designation and sets PDUFA action goal date of April 30, 2026 NEW YORK, Dec. 31, 2025 (GLOBE NEWSWIRE) -- Axsome Therapeutics, Inc. (NASDAQ: AXSM), a...
-
BioAtla will receive an initial $5 million for general operating and Phase 3 clinical trial expenses to advance Oz-V in 2L+ OPSCC with the remaining $35 million anticipated to close in Q1 2026.BioAtla...
-
Nutriband New Year Letter to Shareholders
-
New Drug Application (NDA) submission on track for January 2026 NEW YORK, Dec. 31, 2025 (GLOBE NEWSWIRE) -- Axsome Therapeutics, Inc. (NASDAQ: AXSM), a biopharmaceutical company leading a new era...
-
SHANGHAI, Dec. 31, 2025 (GLOBE NEWSWIRE) -- Smart Share Global Limited (Nasdaq: EM) (“Energy Monster” or the “Company”), a consumer tech company providing mobile device charging service, today...
-
OBOOK Holdings (NASDAQ: OWLS) begins executing its up to $10M Class A share repurchase program, per Rule 10b-18 and market conditions.
-
BUKIT MERTAJAM, MALAYSIA, Dec. 31, 2025 (GLOBE NEWSWIRE) -- CCH Holdings Ltd (the “Company”), a Malaysia-based specialty hotpot restaurant chain, today announced that the underwriters of its...
-
BUKIT MERTAJAM, MALAYSIA, Dec. 31, 2025 (GLOBE NEWSWIRE) -- CCH Holdings Ltd (the “Company”), a Malaysia-based specialty hotpot restaurant chain, today announced the closing of its initial public...